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a  b  s  t  r  a  c  t
Gastroenteritis is one of the most common diseases during childhood, with norovirus (NoV)
and  sapovirus (SaV) being two of its main causes. This study reports for the ﬁrst time the
incidence of these viruses in hospitalized children with and without gastroenteritis in São
Luís,  Maranhão. A total of 136 fecal samples were tested by enzyme immunoassays (EIA) for
the  detection of NoV and by reverse transcription-polymerase chain reaction (RT-PCR) for
detection of both NoV and SaV. Positive samples for both agents were subjected to sequenc-
ing.  The overall frequency of NoV as detected by EIA and RT-PCR was  17.6% (24/136) and
32.6% (15/46), respectively in diarrheic patients and 10.0% (9/90) in non-diarrheic patients
(p  < 0.01). Of the diarrheic patients, 17% had fever, vomiting and anorexia, and 13% devel-
oped  fever, vomiting and abdominal pain. Of the 24 NoV-positive samples, 50% (12/24) were
sequenced and classiﬁed as genotypes GII.3 (n = 1), GII.4 (6), GII.5 (1), GII.7 (2), GII.12 (1)
and  GII.16 (1). SaV frequency was 9.8% (11/112), with 22.6% (7/31) in diarrheic patients and
4.9%  (4/81) in nondiarrheic (p = 0.04) ones. In diarrheic cases, 27.3% had fever, vomiting and
anorexia, whereas 18.2% had fever, anorexia and abdominal pain. One SaV-positive sample
was sequenced and classiﬁed as GII.1. These results show a high genetic diversity of NoV
and higher prevalence of NoV compared to SaV. Our data highlight the importance of NoV
and  SaV as enteropathogens in São Luís, Maranhão.© 2016 Sociedade Bras
an  open access arti
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ntroduction
cute gastroenteritis (AG) is considered to be the second lead-
ng cause of death due to infection1 mainly in children under
ve years old, leading to nearly 760,000 deaths each year, with
5% of episodes caused by viruses.2–4
Among the main causes of viral gastroenteritis, two mem-
ers of the Caliciviridae family are epidemiologically relevant:
orovirus (NoV) and sapovirus (SaV). The relevance of NoV as
 major cause of AG outbreaks has already been established,5
s well as its role in episodes of diarrhea that require hospital-
zation or visits to outpatient clinics.6 SaV are predominantly
elated to sporadic episodes and outbreaks of diarrhea in
ndoors environments, such as daycare centers, and are also
ssociated with AG at different ages.7
NoV and SaV are non-enveloped viruses with diameters of
7–40 nm,  and both are composed of a single-stranded RNA
enome. The NoV is classiﬁed into six genogroups, with sev-
ral genotypes in the GI, GII and GIV genogroups known to
ause AG in humans.8,9 GII.4 is currently regarded as the most
requent genotype, being related to approximately 70% of out-
reaks, and the global epidemics that have occurred since 1995
ave been caused by seven GII.4 variants.9–11 The SaV genus is
ivided into ﬁve genogroups, four of which can infect humans
GI-II, GIV and GV), with GI described as the most common.8,12
he transmission of both viruses occurs primarily by the fecal-
ral route through direct interpersonal contact, ingestion of
ontaminated food and water and possibly by aerosolized par-
icles from vomiting.13 It is believed that for NoV, fresh foods
uch as fruits are those most likely to be contaminated, and
his probably occurs during irrigation.6
Cases of asymptomatic infection vary from 12% to 30%,
hich may represent a transmission facilitator.14,15 The period
f incubation of these pathogens ranges from 24 to 48 h, with
ymptoms persisting from 12 to 72 h. The clinical manifesta-
ions vary from severe to moderate, mainly in NoV cases, with
iarrhea, vomiting, nausea, and fever that sometimes lead to
ehydration, particularly in children and the elderly, which
ay lead to fatal outcomes.16
Research conducted in hospitals, clinics and communities
n several locations in Brazil showed NoV occurrence ranging
rom 8.6% to 39.7%.15,17–20 However, studies involving these
iruses are scarce in the north and northeast regions.
In this study, we sought to determine the prevalence of and
artially characterize NoV and SaV in hospitalized children
ith or without diarrhea in the city of São Luís, Maranhão,
razil, during the period from 1997 to 1999.
aterials  and  methods
ocation  of  study  and  patients
 total of 250 stool samples were obtained from children less
han three years old who  were hospitalized with diarrhea or
ther symptoms at the Materno Infantil Unit at the Univer-
itary Hospital (HUMI) of the Federal University of Maranhão
UFMA) from June 1997 to June 1999. Previously, these sam-
les were tested for rotavirus (RV)21 and astrovirus (AstV),22o l o g y 4 7 (2 0 1 6) 724–730 725
and only the samples with negative results for both viruses
were used in the present study. All samples were stored at
−20 ◦C, and 136 specimens (46 diarrheic and 90 without diar-
rhea) were selected for this research. This study was approved
by the Evandro Chagas Institute Ethical Committee under the
number 284.852.
Fecal  suspensions  and  enzyme  immunoassay  (EIA)
Fecal suspensions were prepared at a dilution of 10%
(weight/volume) and were tested for the presence of NoV
using a commercial enzyme immunoassay (EIA) (3rd gener-
ation RIDASCREEN® Norovirus EIA, R-Biopharm, Darmstadt,
Germany) according to the manufacturer’s recommendations.
Viral  RNA  extraction  and  reverse  transcription  (RT)
A volume of 300 l of fecal suspension was used for nucleic
acid extraction by the silica method23 with a ﬁnal volume of
45 l that was stored at −20 ◦C until use. A volume of 6 l of
RNA was used to obtain the complementary DNA (cDNA) by
reverse transcription (RT) using a random primer.
Molecular  detection
The specimens were screened by polymerase chain reaction
(PCR) with the primers Mon431/Mon433 and Mon432/Mon434,
which are speciﬁc for the NoV RNA polymerase sequences of
genogroups I and II, respectively.24 Samples that tested neg-
ative with this pool of primers were also tested with primers
P289/P290 for the detection of SaV.25
All NoV-positive samples were subjected to two other PCR
analyses: the ﬁrst one ampliﬁed part of the viral capsid region
of NoV (Cap A, B2, B1 and Cap C, D3, D1)26 and the other
ampliﬁed the B (polymerase) and C (capsid) junction regions
(primers G2SKR and Mon/432).27
Puriﬁcation  and  sequencing  of  RT-PCR  calicivirus
amplicons
The samples subjected to nucleotide sequencing were puriﬁed
with the QIAquick® PCR Puriﬁcation (Qiagen) and QIAquick®
Gel Extraction (Qiagen) commercial kits according to the man-
ufacturer’s instructions and sequenced using the Big Dye
Terminator kit (v.3.1) (Applied Biosystems) in an automatic
sequencer. The analysis and editing of the chromatograms
were performed by the BioEdit Sequence Alignment Editor
(v. 7.0) program and compared to other sequences stored in
GenBank with the BLAST program. Phylogenetic grouping was
constructed using maximum likelihood analysis. The evolu-
tionary model selected for the polymerase tree was TPM3+G4
and for the capsid tree was the TIM2e+G4. For both trees, test-
ing was performed with 1000 bootstrap replicates, and the
cut-off value was 70%.
Statistical  analysisStatistical analysis was performed using BioEstat 5.0
software.28 The odds ratio test was used to correlate infection
with age ranges. The chi-square test and Fisher’s exact test
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Table 1 – Detection of norovirus and sapovirus in fecal samples collected from hospitalized children with and without
diarrhea from São Luís, Maranhão from June 1997 to June 1999.
Samples NoV SaV
POS (%) NEG (%) POS (%) NEG (%)
Diarrheal 15 (32.6) 31 (67.4) 7 (22.6) 24 (77.4)
Non-diarrheal 9 (10) 81 (90) 4 (4.9) 77 (95.1)
Total 24 (17.6) 112 (82.4) 11 (9.8) 101 (90.2)
Table 2 – Distribution of norovirus genotypes detected in fecal samples collected from hospitalized children with and
without diarrhea in São Luís, Maranhão from June 1997 to June 1999.
Samples Nucleotide  sequencing Total








Non-diarrheal GII.P4 GII.4  GII.4 4
GII.P7
Total 5 1 
were used to determine whether the results for the two
groups (NoV and SaV) were statistically signiﬁcant. Simple
regression analysis was used to relate each symptom to NoV
and SaV infections.
Results
The NoV frequency was 17.6% (24/136), with 75% (18/24)
detected only by PCR and 25% (6/24) detected by both PCR and
EIE. For SaV, the frequency was 9.8% (11/112). Of the two groups
studied (i.e., with and without diarrhea), the ﬁrst displayed a
higher incidence of infection for both viruses: NoV (32.6% –
p < 0.012) and SaV (22.6% – p < 0.04) (Table 1).
Of the 24 NoV-positive samples, 50% (12/24) were used to
perform nucleotide sequencing, with 66.7% (8/12) from diar-
rheic patients and 33.3% (4/12) from the non-diarrheic group.
In the diarrheic group, three samples were characterized
as genotype GII.4 and ﬁve as genotypes GII.3, GII.5, GII.7, GII.12
and GII.16 (one each). In the non-diarrheic group, two samples
were characterized as GII.4 and two as GII.7.
Of the 12 samples characterized, four were sequenced with
primers targeting two regions: region B (RdRp) and region D
(viral capsid), with the genotypes conﬁrmed in both regions as
GII.3 and GII.16 and two as GII.4. Two samples were sequenced
using the junction region and were classiﬁed as genotypes
GII.4 and GII.5. Five other samples were characterized by the
Table 3 – Frequency by age of positive cases for norovirus and s
gastroenteritis, June 1997 to June 1999 in São Luís, Maranhão.
Age Diarrheic patients 
NoV+/total (%) SaV+/total (%) NoV
0 < 6 1/5 (20) 1/5 (20) 
6 < 12 11/23 (47.9) 1/23 (4.5) 
12 < 18 3/13 (23.1) 2/13 (15.5) 
18 < 24 0/5 (0) 3/5 (60) 
No speciﬁed – – 
Total 15/46 (32.6) 7/46 (15.2) 4 2 12
RdRp region B, with three classiﬁed as GII.P4 and two  as GII.P7.
One sample was characterized as GII.12 by region D of the viral
capsid (Table 2 and Figs. 1 and 2).
No positive samples were characterized as NoV genogroup
I. One diarrheic sample was sequenced for SaV and classiﬁed
as GII.1.
The highest NoV frequency according to age groups was
found between 6 and 12 months of age (OD = 1.7%, p < 0.2) and
for SaV frequency, between 18 months to two years of age
(Table 3).
In addition to diarrhea, the other four clinical symptoms
(fever, vomiting, anorexia and abdominal pain) in the symp-
tomatic patients were analyzed. Fever was the only symptom
that showed a statistically signiﬁcant association (p < 0.04).
Of the positive cases for NoV, 28.6% had fever, vomiting and
anorexia, and 21.6% had fever, vomiting and abdominal pain.
Of the cases positive for SaV, 42.8% were associated with fever,
vomiting and anorexia, and 28.6% with fever, anorexia and
abdominal pain. The analysis of the symptoms of NoV- and
SaV-positive cases is shown in Table 4.Discussion
Currently, studies related to the circulation of these pathogens
in northeastern Brazil are scarce, and this is the ﬁrst study to
apovirus in hospitalized children with and without acute
Non-diarrheic patients Total
+/total (%) SaV+/total (%)
1/12 (8.3) 2/12 (16.6) 5/17 (29.4)
5/47 (10.7) 0/47 (0) 17/70 (24.3)
0/18 (0) 2/18 (11.1) 7/31 (22.6)
1/7 (14.2) 0/7 (0) 4/12 (33.3)
2/6 (33.3) 0/6 (0) 2/6 (33.3)
9/90 (10) 4/90 (4.4) 35/136 (25.7)
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Fig. 1 – Phylogenetic tree based on the polymerase sequence of norovirus. The study samples are marked in bold, and the
tree was constructed using maximum likelihood analysis. The evolutionary model selected for the polymerase tree was
TPM3+G4. The test was performed with 1000 bootstrap replicate
Table 4 – Analysis of the clinical symptoms presented by
children hospitalized with acute gastroenteritis positive
for norovirus and sapovirus in São Luís, Maranhão, from
June 1997 to June 1999.
Symptoms Positive cases
NoV (%) SaV (%)
Vomit 1 (7.1) –
Vomit/anorexia 1 (7.1) –
Vomit/anorexia/abdominal pain 1 (7.1) –
Vomit/fever/anorexia 4 (28.6) 3 (42.8)
Vomit/fever/abdominal pain 3 (21.6) –
Vomit/fever/anorexia/abdominal pain 2 (14.2) 1 (14.3)
Fever/anorexia 1 (7.1) 1 (14.3)







third speciﬁc for the junction region (region B, ORF1 and regionIn the non-diarrheic cases, nine samples were positive for NoV and
four to SaV.
nvestigate the prevalence of these viruses in São Luís, state
f Maranhão.
In the present study, the prevalence of NoV infection
17.6%) in cases of hospitalized children with and without
astrointestinal infection was higher than that detected in
hildren less than ﬁve years old in the state of Acre (north)s, and the cut-off value was 70%.
(12.7%),29 similar to the results found in an African descend-
ant community in Pará (north) (19.7%)30 and lower than that
detected in Niterói (southeast) (30.3%),15 where most infec-
tions by NoV were recorded in children less than two years of
age. For SaV, the incidence was higher (11%) than that detected
in the United States (5%)31 and in Italy (3%).32
Of the total samples analyzed, the highest prevalence was
observed among diarrheic patients, which was signiﬁcant for
both NoV (32.6% – p < 0.012) and SaV (22.6% – p < 0.04). These
ﬁndings corroborate the results obtained for NoV in a study
conducted in São Paulo (southeast) (36.2%)17 and also in Belém
(north) (35.4%),33 both reporting increased frequency of this
pathogen in symptomatic patients. With regard to SaV, the
prevalence detected in the present study for symptomatic
patients was less than that observed in India (39%).34 Detec-
tion of asymptomatic cases emphasizes that even without
clinical signs, viral dispersion may be taking place, which is
another source of transmission of this pathogen.
In the present study, NoV was determined by three different
sets of primers, one speciﬁc for the RNA polymerase (region B,
ORF1), another speciﬁc for the capsid (region D, ORF2) and theC, ORF2). Nucleotide sequences allowed classiﬁcation of the
six samples as genotype GII.4. According to the literature, cur-
rently, strains belonging to this genogroup are showing higher
728  b r a z i l i a n j o u r n a l o f m i c r o b i o l o g y 4 7 (2 0 1 6) 724–730
Fig. 2 – Phylogenetic tree based on the capsid region of norovirus. The study samples are marked in bold, and the tree was
constructed using maximum likelihood analysis. The evolutionary model selected for the polymerase tree was TIM2e+G4,
and tand the test was performed with 1000 bootstrap replicates, 
frequencies in cases of acute gastroenteritis around the world,
accounting for up to 80% of outbreaks worldwide and leading
to the emergence of new variants every two or three years.35–37
Two samples were grouped as genotype GII.12 and GII.16.
GII.12 has been associated with outbreaks in the years 2009
and 2010, with 16% of gastroenteritis in the United States38
caused by NoV and was ﬁrst described in Brazil in 2009, simul-
taneously with GII.16.20 Our study demonstrates that these
two strains were already circulating in São Luís, Maranhão in
the years 1997 and 1999, respectively.
We  also detected the genotypes GII.3 and GII.7. GII.3
strains are usually associated with sporadic cases of infection
among breastfeeding infants, especially those younger than
six months old, besides being reported together with pan-
demic strains of GII.4 in foodborne outbreaks.39 All samples
showed negative results for NoV GI. Most studies have demon-
strated higher prevalence of NoV GII, which may be related to
their broad genetic diversity.40
The GII.4 genotype was predominant, in accordance with
other studies that reported a higher prevalence of thishe cut-off value was 70%.
genotype; however, ﬁve other types were also observed dur-
ing the period of 1997–1999, showing genetic diversity among
strains circulating in this population. This fact could inﬂuence
the future development and implementation of a possible vac-
cine against NoV.
One SaV sample was sequenced and classiﬁed as GII.1. This
genotype was also detected in the stool sample of a child with
AG in a study carried out in Salvador, Brazil, in 200241 and
described in the metropolitan region of Belém, being present
in ten of the ﬁfteen (66.7%) samples characterized.42
The age group most affected by NoV was children between
six months and one year of age (47.9%). This prevalence was
higher than that found in Peru (9%)43 and reinforces the data
found in Burkina Faso44 and in Belém,45 where 36% and 45.1%,
respectively, of children at this age were infected with NoV,
while much lower frequencies were found in those that were
older than two years. SaV was more  prevalent among children
eighteen months to two years old. These results differ from
those described in Japan, where SaV was associated with chil-
dren 36 months of age (91%).46 However, it is important to take
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nto account the limited number of cases analyzed in each
roup in the present study.
Considering diarrhea as the inclusion criteria, this study
xamined the prevalence of other clinical manifestations that
ere present in the majority of positive cases, such as vomi-
ing, anorexia and fever. These symptoms may be related to
he clinical condition caused by NoV and SaV, as demonstrated
y Nordgren et al.,44 who  found an association with anorexia
62%), fever (49%) and vomiting (49%) among the positive cases
or NoV. In addition to that, distress was described in some
ositive cases.
One limitation of the present study is that we only tested
amples negative for RV and HAstV, even though co-infection
nvolving enteric viruses is relatively common in cases of
cute gastroenteritis as suggested by some reports on this
atter.18,47,48 In Brazil, Victoria et al.49 reported in hospital-
zed children from Rio de Janeiro a rate of 4% co-infection by
V and NoV.
Although this study was conducted with samples collected
n 1997–1999, our data may be useful as a reference for possible
uture molecular epidemiological studies (including evolu-
ionary analyses) on NoV and SaV infections in Brazil.
onclusion
he presence of NoV and SaV in hospitalized children in São
uís, Maranhão, reinforces that this age group is susceptible
o infection by these agents, in line with general reports in
he literature. The higher number of positive cases in symp-
omatic patients was expected, and our results also emphasize
he diversity of genotypes found in the samples. These results
emonstrate the circulation of NoV and SaV and indicate that
ore  studies are necessary, considering that epidemiological
nformation about these viruses in São Luis, Maranhão is still
imited.
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